long story short they have not reached a trial end point so they don’t report on individual cases. The fact they gave an update in the quarterly is above and beyond what other biotechs would have done.
don’t see an issue here, Monepantel is not a cure it’s a treatment. The test is only whether it prolongs survival longer than current standard of care around 6-9 months.
i am interested to see who steps into the ring as CEO in coming months.
- Forums
- ASX - By Stock
- PAA
- The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1228
-
- There are more pages in this discussion • 197 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
20.0¢ |
Change
0.005(2.56%) |
Mkt cap ! $97.22M |
Open | High | Low | Value | Volume |
19.5¢ | 20.0¢ | 19.5¢ | $199.9K | 1.004M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 457971 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 1207 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 442587 | 0.195 |
15 | 834741 | 0.190 |
12 | 251176 | 0.185 |
19 | 360473 | 0.180 |
2 | 255530 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 1207 | 1 |
0.205 | 172264 | 2 |
0.210 | 178232 | 4 |
0.215 | 353018 | 4 |
0.220 | 479713 | 7 |
Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online